Inflammation as a risk factor for carotid intimal-medial thickening, a measure of subclinical atherosclerosis in haemodialysis patients: The role of chlamydia and cytomegalovirus infection

被引:18
作者
Buyukhatipoglu, Hakan
Tiryaki, Ozlem
Tahta, Kadir
Usalan, Celalettin
机构
[1] Gaziantep Univ, Fac Med, Div Nephrol, Gaziantep, Turkey
[2] Gaziantep Univ, Fac Med, Dept Internal Med, Gaziantep, Turkey
关键词
acute phase response; atherosclerosis; carotid intima-media thickness; chlarnydia pneumonia infection; cytomegalovirus infection; haemodialysis;
D O I
10.1111/j.1440-1797.2006.00742.x
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objectives: Atherosclerotic vascular disease is the most frequent complication seen in haemodialysis (HD) patients. Evidence suggests that inflammation may play a role in the pathogenesis and progression of atherosclerosis. Our aim was to evaluate the causative role of inflammation in atherosclerosis among HD patients. Methods: Intima-media thickness (IMT) in carotid arteries was determined in 54 HD patients and 52 controls. Plasma levels of lipids, glucose, albumin and several acute phase proteins, and immunoglobulin G titres against chlamydia and cytomegalovirus were measured in all subjects. Results: Mean carotid IMT was significantly greater in HD patients than in controls (0.75 mm vs 0.56 mm, P < 0.005). While plasma levels of C-reactive protein (CRP), serum amyloid A (SAA), lipoprotein (a) Lp(a), fibrinogen and ferritin were higher in HD patients, albumin levels were lower. In HD patients, carotid IMT was correlated positively with CRP (R = 0.29, P = 0.019), SAA (R = 0.69, P < 0.001), Lp(a) (R = 0.42, P = 0.001), fibrinogen (P = 0.57, P < 0.001) and chlamydia pneumonia immunoglobulin G titres (R = 0.50, P < 0.001), and negatively with albumin levels (R = -0.33, P = 0.02); there was no relationship between carotid IMT and hypertension, plasma lipid levels and cytomegalovirus. In multivariate regression analysis, these variables still showed a significant relationship with IMT (R-2 = 0.694 and P < 0.001). Conclusion: We conclude that atherosclerotic changes are more common in HD patients than in controls, and that inflammatory processes may play a role in the pathogenesis of atherosclerosis.
引用
收藏
页码:25 / 32
页数:8
相关论文
共 46 条
[1]   LIPID ABNORMALITIES IN RENAL-DISEASE [J].
APPEL, G ;
SCHAEFER, E ;
MADIAS, NE ;
MADAIO, MP ;
HARRINGTON, JT ;
LEVEY, AS ;
NARAYAN, G ;
MEYER, K .
KIDNEY INTERNATIONAL, 1991, 39 (01) :169-183
[2]  
ATTMAN PO, 1991, KIDNEY INT, V39, pS16
[3]  
BERGSTROM J, 1995, J AM SOC NEPHROL, V6, P573
[4]   ELEVATION OF C-REACTIVE PROTEIN IN ACTIVE CORONARY-ARTERY DISEASE [J].
BERK, BC ;
WEINTRAUB, WS ;
ALEXANDER, RW .
AMERICAN JOURNAL OF CARDIOLOGY, 1990, 65 (03) :168-172
[5]  
CAMEJO G, 1988, BIOMED BIOCHIM ACTA, V47, P239
[6]  
Cianciaruso B, 1984, Contrib Nephrol, V41, P438
[7]   LIPOPROTEIN(A) IS AN INDEPENDENT RISK FACTOR FOR CARDIOVASCULAR-DISEASE IN HEMODIALYSIS-PATIENTS [J].
CRESSMAN, MD ;
HEYKA, RJ ;
PAGANINI, EP ;
ONEIL, J ;
SKIBINSKI, CI ;
HOFF, HF .
CIRCULATION, 1992, 86 (02) :475-482
[8]   ELEVATED SERUM LEVELS OF C-REACTIVE PROTEIN IN HEMODIALYSIS-PATIENTS [J].
DOCCI, D ;
BILANCIONI, R ;
BUSCAROLI, A ;
BALDRATI, L ;
CAPPONCINI, C ;
MENGOZZI, S ;
TURCI, F ;
FELETTI, C .
NEPHRON, 1990, 56 (04) :364-367
[9]  
EPSTEIN SE, 1996, LANCET S, V348, P13
[10]   FIBRINOGEN - ITS EMERGING ROLE AS A CARDIOVASCULAR RISK FACTOR [J].
ERNST, E .
ANGIOLOGY, 1994, 45 (02) :87-93